Biotricity is trading at $0.05, down 14.18%, with no clear company-specific catalyst identified.
- The company newsroom lists no announcement for October 21, 2026.
- Healthcare is up 2.12%, but that sector gain does not explain the decline.
- Supplied broad-market figures are mixed, and no trading-volume figure was available in the provided price context, leaving the cause unclear.